Abstract
Duodenogastric reflux has a deleterious effect on the gastric mucosa. It was the aim of this study to assess the acute effects of cisapride on antroduodenal motility and duodenogastric reflux in seven patients with severe dyspepsia and increased biliary reflux, as evidenced by increased bile salt output in their gastric aspirates. Each patient underwent two studies on separate days. On each day, after an overnight fast, each patient swallowed a multilumen tube for manometric recording of gastroduodenal motility. Phenol red was infused into the second portion of the duodenum, gastric juice was aspirated, and motor activity was monitored for 90 min. At the end of this period, the patient received either cisapride or placebo intravenously in a double-blind randomized fashion. Antroduodenal motility and duodenogastric reflux were monitored for the subsequent 90 min. A significantly (P<0.01) higher motility index was found in the antrum after cisapride (2678±712 vs 1110±412 in the basal period) while placebo had no effect. The duodenal motility index was not affected by cisapride or placebo. Bile salt outputs in gastric aspirates were significantly (P<0.05) reduced following cisapride injection (0.42±0.6 mmol vs 1.6±1.2 mmol during basal period). Conversely, outputs of phenol red in the gastric aspirates were unaffected by cisapride. In conclusion, cisapride stimulates antral motility and decreases biliary reflux in patients with dyspepsia and increased duodenogastric reflux.
Similar content being viewed by others
References
Wormsley RG: Aspects of duodenogastric reflux in man. Gut 13:243–250, 1972
Delaney JP, Cheng JW, Butler BA, Ritchie WP: Gastric ulcer and regurgitation gastritis. Gut 11:715–719, 1979
Lawson HH: Effect of duodenal contents on the gastric mucosa under experimental conditions. Lancet 1:469–472, 1964
Miranda M, Defilippi C, Valenzuela JE: Abnormalities of the interdigestive motility complex and increased duodenogastric reflux in gastric ulcer patients. Dig Dis Sci 30:16–21, 1985
Tolin RD, Malmud LS, Stelzer F, Menin R, Makler PD, Applegate G, Fisher RS: Enterogastric reflux in normal subjects and patients with Billroth II gastroenterostomy. Gastroenterology 77:1027–1033, 1979
Robbins PL, Broodie TA, Sosin H, Delaney JP: Reflux gastritis—the consequences of intestinal juice in the stomach. Am J Surg 131:23–29, 1976
Rhods J, Barnardo DE, Phillips SF, Rovelstad RA, Hofmann AF: Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology 57:241–252, 1969
Thompson WG: Nonulcer dyspepsia. Can Med Assoc J 130:565–569, 1984
Reyntjens A, Verlinden M, De Coster R, Janisch JD, Smout D, De Creg J, Leempaels J, Verhaegen MS: Clinical pharmacological evidence for cisapride's lack of antiadrenaline or direct cholinergic properties. Curr Ther Res 36:1045–1052, 1984
Reboa G, Arnulfo G, Di Somma C, Frascio M, Arzillo G, Berti-Riboli E, Lucchetti G: Prokinetic effects of cisapride on normal antroduodenal motility and reflexes. Curr Ther Res 36:18–23, 1984
Jian R, Ducrot F, Piedeloup C, Mary JY, Najean Y, Bernier JJ: Measurement of gastric emptying in dyspeptic patients: Effect of a new gastrokinetic agent (cisapride). Gut 26:352–358, 1985
Edwards CA, Holden S, Brown C, Read NW: Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects. Gut 28:13–16, 1987
Dixon MF, O'Connor HJ, Axon ATR, King RFJG, Johnston D: Reflux gastritis: Distinct histopathological entity? J Clin Pathol 39:524–530, 1986
Dooley CP, Reznick JB, Valenzuela JE: Variations in gastric and duodenal motility during gastric emptying of liquid meals in humans. Gastroenterology 87:1114–1119, 1984
Pantoja JL, Defilippi C, Valenzuela JE, Csendes A: Nonsteroidal anti-inflammatory drugs: Effect on pyloric sphincter and duodenogastric reflux. Dig Dis Sci 24:217–220, 1979
Talalay P: Analysis of steroid hormones. Methods Biochem Anal 8:119–143, 1960
Muller-Lissner SA, Fimmel CJ, Sonnenberg A, Will N, Muller-Duysing W, Heinzel F, Blum AL: A novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcers. Gut 24:510–518, 1983
Muller-Lissner SA, Frass C: Dissociation of duodenogastric marker reflux and bile salt reflux. Dig Dis Sci 30:733–738, 1985
Keane FB, DiMagno EP, Malagelada JR: Duodenogastric reflux in humans: Its relationship to fasting antroduodenal motility and gastric, pancreatic and biliary secretion. Gastroenterolgy 81:726–731, 1981
Davenport HW: Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology 54:175–181, 1968
Capper WM, Buckler TJ, Kilby JV, Gibson MJ: Gallstones, gastric secretion and flatulent dyspepsia. Lancet 1:413–415, 1967
Hordijk ML, VanRoon F, Silberbusch J: Domperidone decreases duodenogastric reflux in patients with chronic gastritis. Neth J Med 30:172–180, 1987
Miller LJ, Malagelada JR, Longstreth GF, Co VLW: Dysfunction of the stomach with gastric ulceration. Dig Dis Sci 25:857–864, 1980
Francois I, De Nutte N: Cisapride in the treatment of functional nonulcer dyspepsia. Digestion 34:151, 1986 (abstract)
Muller-Lissner SA, Frass C: Chronic oral treatment with cisapride decreases high bile salt reflux rates. Am J Gastroenterol 81:354–357, 1986
Dooley CP, Mello WD, Valenzuela JE: Effects of aspirin and prostaglandin E2 on the interdigestive motility complex and duodenogastric reflux in man. Dig Dis Sci 30:513–521, 1985
Defilippi C, Manari N, Gomez E: Relationship between antropyloric and intestinal motility and duodenogastric reflux in fasting dogs. Dig Dis Sci 32:171–176, 1987
Fisher R, Cohen S: Physicological characteristics of the human pyloric sphincter. Gastroenterology 64:67–75, 1973
Author information
Authors and Affiliations
Additional information
This study was supported in part by a grant from Janssen Pharmaceutical Co. Dr. Rezende-Filho is from the Instituto de Gastroenterologia de Goiania, Goiania, Brazil, and was supported by a Brazilian Council of Scientific and Technological Development Scholarship. Dr. Di Lorenzo is from the University of Napoli, Napoli, Italy.
Rights and permissions
About this article
Cite this article
Rezende-Filho, J., Di Lorenzo, C., Dooley, C.P. et al. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia. Digest Dis Sci 34, 1057–1062 (1989). https://doi.org/10.1007/BF01536374
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01536374